文献速递血管炎

根据EULAR定义分析巨细胞动脉炎主要与次要复发的流行病学:来自ARTESER登记研究的见解

Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

基于西班牙多中心ARTESER登记研究,回顾性分析1284例随访至少1年的巨细胞动脉炎(GCA)患者,按2018年EULAR定义分类复发。26%患者出现复发,1至4年累积复发率分别为18.1%、27.9%、37.6%和44.8%;主要复发占全部复发的26.7%,影响7.6%的患者。诊断时严重缺血并发症(HR 4.126,P<0.001)和大血管受累(HR 1.992,P=0.024)显著增加主要复发风险。

要点

  • 26%的GCA患者出现复发,4年累积复发率达44.8%。
  • 主要复发占全部复发的26.7%,影响7.6%的患者。
  • 诊断时严重缺血并发症和大血管受累显著增加主要复发风险。

核心结论

  • 主要复发并不少见,占全部复发的四分之一。
  • 诊断时存在严重缺血并发症和大血管受累大幅增加主要复发风险。

研究设计与样本

  • 对西班牙多中心GCA登记研究(ARTESER)中患者进行回顾性分析,纳入1284例随访至少1年的患者,复发按2018年EULAR定义分类。

主要发现

  • 26%的患者经历复发,1、2、3、4年累积复发率分别为18.1%、27.9%、37.6%和44.8%。
  • 第一年14.6%的患者出现多次复发,第二年10.5%,第三年9%,第四年17.8%。
  • 按EULAR定义,主要复发占全部记录复发的26.7%,影响7.6%的患者。
  • 诊断时较年轻(HR 0.976,P=0.004)和首次复发时较高泼尼松总剂量(HR 0.998,P=0.003)与总体复发风险降低相关。
  • 诊断时严重缺血并发症(HR 4.126,P<0.001)和大血管受累(HR 1.992,P=0.024)显著增加主要复发风险,较年轻(HR 0.970,P=0.002)对次要复发有保护作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence, timing and risk factors at diagnosis associated with relapses in giant cell arteritis (GCA), with a separate analysis of major and minor relapses. METHODS: A retrospective review of patients from the Spanish multicentre GCA registry (ARTESER) was conducted. Relapses were classified using 2018 EULAR definitions. RESULTS: We included 1284 patients with at least one year of follow-up. Twenty-six percent experienced relapses, with cumulative rates of 18.1%, 27.9%, 37.6% and 44.8% at 1, 2, 3 and 4 years, respectively. Multiple relapses were observed in 14.6% of patients during the first year, 10.5% in the second, 9% in the third and 17.8% in the fourth, reflecting the relapsing-remitting nature of GCA. According to EULAR definitions, major relapses represented 26.7% of all recorded relapses and affected 7.6% of patients. Younger age at diagnosis (HR: 0.976, P = 0.004) and a higher total dose of prednisone at the first relapse (HR: 0.998, P = 0.003) were associated with a reduced risk of overall relapses. Severe ischemic complications (HR: 4.126, P < 0.001) and large-vessel (LV) involvement at diagnosis (HR: 1.992, P = 0.024) significantly increased the risk of major relapses, while younger age (HR: 0.970, P = 0.002) was protective against minor relapses. CONCLUSIONS: Major relapses are not so uncommon, representing a quarter of all relapses. The presence of severe ischemic complications and LV involvement at diagnosis substantially increase their risk.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Narváez J, Domínguez-Álvaro M, Hernández-Rodríguez I, et al. Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry. Rheumatology (Oxford). 2025. PMID: 40343487. doi:10.1093/rheumatology/keaf237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。